D.E. Shaw & Co’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Buy |
273,535
+56,004
| +26% | +$402K | ﹤0.01% | 1917 |
|
|
2025
Q1 | $1.3M | Sell |
217,531
-122,457
| -36% | -$734K | ﹤0.01% | 2061 |
|
|
2024
Q4 | $2.65M | Sell |
339,988
-117,240
| -26% | -$914K | ﹤0.01% | 1657 |
|
|
2024
Q3 | $4.94M | Buy |
457,228
+158,517
| +53% | +$1.71M | ﹤0.01% | 1307 |
|
|
2024
Q2 | $2.52M | Sell |
298,711
-152,521
| -34% | -$1.29M | ﹤0.01% | 1651 |
|
|
2024
Q1 | $3.03M | Buy |
451,232
+392,431
| +667% | +$2.64M | ﹤0.01% | 1539 |
|
|
2023
Q4 | $346K | Sell |
58,801
-51,725
| -47% | -$304K | ﹤0.01% | 2514 |
|
|
2023
Q3 | $1.08M | Sell |
110,526
-91,630
| -45% | -$893K | ﹤0.01% | 1999 |
|
|
2023
Q2 | $2.39M | Sell |
202,156
-259,678
| -56% | -$3.07M | ﹤0.01% | 1652 |
|
|
2023
Q1 | $4.98M | Sell |
461,834
-271,626
| -37% | -$2.93M | 0.01% | 1341 |
|
|
2022
Q4 | $8.48M | Sell |
733,460
-166,613
| -19% | -$1.93M | 0.01% | 1085 |
|
|
2022
Q3 | $13.4M | Buy |
900,073
+704,172
| +359% | +$10.5M | 0.02% | 753 |
|
|
2022
Q2 | $1.77M | Buy |
+195,901
| New | +$1.77M | ﹤0.01% | 2337 |
|
|
2022
Q1 | – | Sell |
-25,813
| Closed | -$221K | – | 4280 |
|
|
2021
Q4 | $221K | Buy |
+25,813
| New | +$221K | ﹤0.01% | 3445 |
|
|
2019
Q1 | – | Sell |
-13,739
| Closed | -$242K | – | 2565 |
|
|
2018
Q4 | $242K | Buy |
13,739
+961
| +8% | +$16.9K | ﹤0.01% | 2319 |
|
|
2018
Q3 | $526K | Buy |
+12,778
| New | +$526K | ﹤0.01% | 2069 |
|